(Q28188068)
Statements
A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity (English)
0 references
15 March 2004
0 references
103
0 references
6
0 references
2299-307
0 references